Your browser doesn't support javascript.
loading
Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study.
Adler, Lenard; Tanaka, Yoko; Williams, David; Trzepacz, Paula T; Goto, Taro; Allen, Albert J; Escobar, Rodrigo; Upadhyaya, Himanshu P.
Affiliation
  • Adler L; From the *New York University School of Medicine; and †New York VA Harbor Healthcare System, New York, NY; ‡Eli Lilly and Company, Neuroscience, Indianapolis, IN; §inVentiv Health Clinical, LLC, Ann Arbor, MI; ∥University of Mississippi Medical School, Jackson, MS; ¶Tufts University School of Medicine, Boston, MA; #Indiana University School of Medicine, Indianapolis, IN; and **Lilly Research Laboratories, Kobe, Japan.
J Clin Psychopharmacol ; 34(4): 461-6, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24977716
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Propylamines / Attention Deficit Disorder with Hyperactivity / Substance Withdrawal Syndrome / Adrenergic Uptake Inhibitors / Executive Function Type of study: Clinical_trials / Diagnostic_studies / Qualitative_research Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychopharmacol Year: 2014 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Propylamines / Attention Deficit Disorder with Hyperactivity / Substance Withdrawal Syndrome / Adrenergic Uptake Inhibitors / Executive Function Type of study: Clinical_trials / Diagnostic_studies / Qualitative_research Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychopharmacol Year: 2014 Type: Article Affiliation country: Japan